HR5483-119

What This Bill Does

The Chloe Cole Act defines and restricts certain gender-transition-related medical interventions for minors through civil liability. The bill defines chemical or surgical mutilation to include puberty blockers, sex hormones, and surgeries intended to alter a child's body to no longer correspond to the child's sex, while carving out exceptions for congenital anomalies, disease, traumatic injury, acute illnesses with high mortality risk, and detransition treatment. Section 3, in the source text, prohibits health care professionals, hospitals, and clinics from participating in those procedures for a child when interstate-commerce hooks, federal territories, D.C., or other jurisdictional triggers are present, unless clear and convincing evidence supports an exception. Section 4 lets an individual subjected as a child, or parents or legal guardians, bring a federal civil action for damages against participating professionals, hospitals, or clinics, including compensatory, economic, noneconomic, and punitive damages; post-enactment violations proven by clear and convincing evidence are strictly liable. Section 5 preserves counseling, mental health referrals, and discussion of adult treatment options when they do not constitute participation.

Who Benefits and How

Parents opposing gender-transition procedures for minors benefit because the bill gives them a federal damages action. Individuals who later challenge childhood procedures benefit from a civil remedy for economic, emotional, and punitive damages. Detransition patients benefit because detransition treatment is excluded from the bill's prohibited-procedure definition. Advocacy organizations opposing pediatric gender-transition care benefit from an enforceable federal liability standard.

Who Bears the Burden and How

Gender-affirming care clinicians face new federal civil liability, strict-liability rules, and burden-of-proof requirements. Hospitals offering pediatric gender-transition services must reassess procedures, documentation, exceptions, and legal exposure. Transgender minors seeking covered care face reduced access when providers avoid procedures covered by the bill. Federal courts must hear damages actions and resolve statutory ambiguities under the bill's construction rules.

Key Provisions

• Defines covered chemical and surgical procedures involving puberty blockers, sex hormones, and surgeries for minors.
• Provides exceptions for congenital anomalies, disease, traumatic injury, acute mortality risk, and detransition treatment.
• Prohibits provider, hospital, or clinic participation when federal jurisdictional triggers are present.
• Creates a private right of action for affected individuals, parents, and legal guardians.
• Requires clear and convincing evidence for exceptions and imposes strict liability for proven post-enactment violations.